Europese Unie -
Nederlands -
EMA (European Medicines Agency)
nexviadyme
sanofi b.v. - avalglucosidase alfa - glycogeen opslag ziekte type ii - andere maagdarmkanaal en metabolisme producten, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).
Europese Unie -
Nederlands -
EMA (European Medicines Agency)
pombiliti
amicus therapeutics europe limited - cipaglucosidase alfa - glycogeen opslag ziekte type ii - andere maagdarmkanaal en metabolisme producten, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).
België -
Nederlands -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
calcium gluconate 10 % b. braun inj. opl. i.m./i.v. amp.
b. braun melsungen ag - calciumgluconaat 94 mg/ml - eq. calcium 0,23 mmol/ml - oplossing voor injectie - calciumgluconaat 94 mg/ml - electrolytes
Nederland -
Nederlands -
myHealthbox
roundup® ultimate
bayer ag - waterige oplossing - 480 g/l glyfosaat
Nederland -
Nederlands -
myHealthbox
roundup® dynamic
bayer ag - waterige oplossing - 500 g/l glyfosaat
Europese Unie -
Nederlands -
EMA (European Medicines Agency)
opfolda
amicus therapeutics europe limited - miglustat - glycogeen opslag ziekte type ii - andere voedings- en metabolismeproducten - opfolda (miglustat) is an enzyme stabiliser of cipaglucosidase alfa long-term enzyme replacement therapy in adults with late-onset pompe disease (acid α- glucosidase [gaa] deficiency).